Medical Condition News

RSS

Mesoblast’s MPC therapy for children featured at symposium for congenital heart disease

Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.

26 Sep 2018

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Diabetes is an increasing global epidemic that is expected to grow by more than 50 percent in the next two decades, leaving more than half a billion patients worldwide exposed to potentially life-altering medical complications, including pain and numbness in the feet, lost limbs, life-threatening disorders of the heart, liver and kidneys -- and even blindness.

26 Sep 2018

Urine exRNA may be source of biomarkers for muscular dystrophy

Massachusetts General Hospital researchers have found that extracellular RNA in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.

26 Sep 2018

Study: Second opinion can potentially change the diagnosis of breast cancer patients

It's early morning and a team of more than 20 professionals cram around a long table in a dark room, peering at slide after slide of black-and-white mammogram images crossing the screen.

26 Sep 2018

Exercise and diet may reduce obesogenic effects of PFAS

A new study finds that perfluoroalkyl and polyfluoroalkyl substances are associated with increases in weight, but exercise and diet may reduce the obesogenic effects of these environmental contaminants.

26 Sep 2018

BMI screening tool often fails to identify preschoolers with excess stomach fat

When assessing whether preschoolers are overweight, health professionals should use other measures such as waist-to-height ratio in addition to the Body Mass Index (BMI).

26 Sep 2018

KTU researchers engineer experimental bone to help treat osteoarthritis patients

Researchers from the Faculty of Chemical Technology, Kaunas University of Technology (KTU), Lithuania are developing an artificial bone, which can be used for treating of the most common joint disease - osteoarthritis.

26 Sep 2018

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2018 argue for brigatinib as a first-line treatment option for advanced ALK-positive non-small cell lung cancer.

26 Sep 2018

VRK1 protein may enable cancer cells to colonize new areas of the body during metastasis

Sometimes negative results can point researchers in the right direction. In results published in PLOS ONE on September 4, 2018, scientists at the Medical University of South Carolina examined a protein called vaccinia-related kinase 1 that they hypothesized was important for metastasis. They found that, rather than causing cancer cells to migrate and invade, VRK1 over-expression had the opposite effect.

26 Sep 2018

Alzheimer’s disease researchers makes significant breakthroughs

Researchers in Sweden and United Kingdom have made a breakthrough in Alzheimer’s disease research. They could soon be on the path to develop new drugs that could fight the disease more effectively.

26 Sep 2018

Hybrid operating room enables faster diagnosis, treatment of patients with lung cancer

Representing a paradigm shift in thoracic surgery, the hybrid operating room combines three techniques into a single appointment eliminating multiple clinical visits for improved patient experience and outcomes.

25 Sep 2018

UCI study finds new cause of cerebral microbleeds

A team of researchers including UCI project scientist Rachita Sumbria, PhD and UCI neurologist Mark J. Fisher, MD have provided, for the first time, evidence that blood deposits in the brain may not require a blood vessel tear.

25 Sep 2018

Driver gene mutations found to be common for cancer metastases

Driver genes in different metastases from the same patient are remarkably similar, providing optimism for the success of future targeted therapies, according to a published study by Science.

25 Sep 2018

Novel drug alleviates memory deficits and neuropathology in Alzheimer's animal model

New research conducted at the Lady Davis Institute at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology in an animal model.

25 Sep 2018

Increased physical activity associated with improvement in IBS symptoms

Increased physical activity is now being emphasized as a treatment option for the gastric intestinal disease known as IBS. Research at Sahlgrenska Academy, Sweden, indicates improvements in both intestinal function and self-esteem of patients who exercise more.

25 Sep 2018

Patients with paralysis manage to walk thanks to new technology

Two of four participants in a study conducted at the Kentucky Spinal Cord Injury Research Center at the University of Louisville (UofL) have managed to walk over ground after having suffered traumatic complete spinal cord injury.

25 Sep 2018

FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome

Myelo Therapeutics GmbH announced today that the US Food and Drug Administration has granted an Orphan Drug Designation to its orally applied new chemical entity Myelo001 for the treatment of Acute Radiation Syndrome.

25 Sep 2018

NeoTract presents new clinical data from studies of UroLift System for patients with BPH

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the World Congress of Endourology 2018 Annual Conference from two U.K. studies of the company's novel UroLift System for patients with Benign Prostatic Hyperplasia.

25 Sep 2018

Cerevance starts dosing in Phase I clinical trial of CVN424 for treatment of Parkinson's disease

Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.

25 Sep 2018

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Following the closure of several research programs for Alzheimer's disease, in early 2018 the FDA issued a release entitled "Draft Guidance for Industry: Early Alzheimer's Disease: Developing Drugs for Treatment." Encouraged by the proposed changes in the new guidance, Genervon's research team reported new findings that its drug candidate GM6 attenuates Alzheimer's disease in an early AD transgenic APP mice model.

25 Sep 2018

Medical Condition News

Mesoblast’s MPC therapy for children featured at symposium for congenital heart disease

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Urine exRNA may be source of biomarkers for muscular dystrophy

Study: Second opinion can potentially change the diagnosis of breast cancer patients

Exercise and diet may reduce obesogenic effects of PFAS

BMI screening tool often fails to identify preschoolers with excess stomach fat

KTU researchers engineer experimental bone to help treat osteoarthritis patients

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

VRK1 protein may enable cancer cells to colonize new areas of the body during metastasis

Alzheimer’s disease researchers makes significant breakthroughs

Hybrid operating room enables faster diagnosis, treatment of patients with lung cancer

UCI study finds new cause of cerebral microbleeds

Driver gene mutations found to be common for cancer metastases

Novel drug alleviates memory deficits and neuropathology in Alzheimer's animal model

Increased physical activity associated with improvement in IBS symptoms

Patients with paralysis manage to walk thanks to new technology

FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome

NeoTract presents new clinical data from studies of UroLift System for patients with BPH

Cerevance starts dosing in Phase I clinical trial of CVN424 for treatment of Parkinson's disease

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News